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To compare the complications and mortality related to gastrostomy procedures performed using surgical and
percutaneous endoscopic gastrostomy techniques, this review covered seven studies. Five of these were
retrospective and two were randomized prospective studies. In total, 406 patients were involved, 232 of whom
had undergone percutaneous endoscopic gastrostomy and 174 of whom had undergone surgical gastrostomy.
The analysis was performed using Review Manager. Risk differences were computed using a fixed-effects model
and forest and funnel plots. Data on risk differences and 95% confidence intervals were obtained using the
Mantel-Haenszel test. There was no difference in major complications in retrospective (95% CI (-0.11 to 0.10)) or
randomized (95% CI (-0.07 to 0.05)) studies. Regarding minor complications, no difference was found in
retrospective studies (95% CI (-00.17 to 0.09)), whereas a difference was observed in randomized studies (95% CI
(-0.25 to -0.02)). Separate analyses of retrospective and randomized studies revealed no differences between
the methods in relation to mortality and major complications. Moreover, low levels of minor complications were
observed among endoscopic procedures in randomized studies, with no difference observed compared with
retrospective studies.
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The use of gastrostomy has expanded over the past
decade, and new techniques have been developed that have
made the procedure simpler and less risky (1). Gastrostomy
is specifically a technique that allows direct access to the
stomach to provide food to disabled patients for several
reasons. Most commonly, this condition occurs in patients
with neurological diseases, impairment following a stroke or
obstructive head and neck tumors (1,2).
The absence of systematic reviews and meta-analyses directly
comparing endoscopic gastrostomy and surgical gastrostomy
(SG) techniques for all pathologies, whether benign or malignant,
in the literature was one of the main reasons for conducting
the present comparative review of surgical and endoscopic
methods for all pathologies that may result in gastrostomy,
taking into account major and minor complications. Two
related reviews were found in the literature, but both of
these considered specific pathologies. The first, carried out
by Grant et al. (9), investigated gastrostomy complications
in patients with head and neck tumors and compared
radiological methods with endoscopy, not considering the
surgical method. The other, by Burkitt et al. (2), similarly
compared complications in patients with head and neck
tumors but did not address other pathologies and only
compared radiological techniques with endoscopy, given
that endoscopic gastrostomy has become the technique of
choice for carrying out the procedure, with SG only used in
cases where the endoscopic procedure is not viable. Most
studies associate SG with higher rates of complications and
mortality (4,7).
Several techniques for gastrostomy tube insertion have
been described. These techniques include percutaneousDOI: 10.6061/clinics/2016(03)09
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endoscopic gastrostomy (PEG) and SG (open SG (OSG) or
surgical laparoscopic gastrostomy (SLG)) (2). SG was initially
suggested in 1837 by Egeberg, a Norwegian surgeon and the
first successful gastrostomy was carried out nearly 40 years
later, in 1876, by Verneuil in Paris, France (1-3).
The SLG method also avoids the need for a laparotomy
but still requires general anesthesia. Although not an
absolute contraindication, prior upper abdominal surgery
may make the SLG method difficult and risky (8). The SLG
method additionally offers better exposure of the stomach
than the open technique, in which the incision is usually
quite small. However, PEG has nearly entirely displaced SG
in clinical practice because the PEG procedure can be carried
out more easily and without general anesthesia, which is
beneficial for the usually elderly, high-risk patient population.
In addition, PEG avoids the mortality and morbidity associated
with laparotomy. Despite the minor invasiveness of endoscopic
placement of percutaneous feeding tubes, complications remain
an important problem (2,3).
There is widespread acceptance of PEG as the insertion
technique of choice owing to its simplicity and effectiveness,
but certain patients are not candidates for an endoscopic
approach (10). The present review provides greater evidence in
the current context as to which of these procedures is associated
with major complications and mortality.
’ METHODS
Protocol and registration
The present review was conducted in accordance with the
PRISMA (Preferred Reporting Items for Systematic reviews and
Meta-Analyses) recommendations (7) and it has been registered
in the PROSPERO international database (www.crd.york.ac.
uk/prospero/) under number CRD42015016493 (20).
Eligibility criteria
a) Types of studies: randomized controlled trials and retro-
spective studies.
b) Type of participant: patients undergoing gastrostomy.
c) Types of interventions: PEG (intervention) and SG
(comparison).
d) Types of outcome measures: the main outcome parameters
were minor and major complications and mortality directly
related to the procedure.
There is no literature on the exact classification of com-
plications related to gastrostomy and authors have classified
these complications in various ways. The methods used
here are those found most often in published studies. Complica-
tions may be secondary to endoscopic procedures or directly
related to gastrostomy, such as cardiopulmonary complications,
hypoxemia, phlebitis, bacteremia, perforation and bleeding.
Minor complications are treated conservatively. Major complica-
tions may require hospitalization (9,2,22), blood transfusions, or
endoscopic or surgical therapy. The period in which complica-
tions occur may be early (until 15 days) or late (after 15 days) (10).
For the present review, both major andminor complications were
considered, whether early or late (2,12,22).
Major complications. Bowel perforation, Gastrointestinal
hemorrhage, Gastrocutaneous fistula, Intra-abdominal abscess,
Peristomal abscess, Peritonitis requiring surgery, Loss of cath-
eter tract, Aspiration pneumonia, Sepsis, Buried bumper syn-
drome, Early inadvertent removal of tube.
Minor complications. Dislodged tubes, Inadvertent removal of
tubes, Tube malfunction, Other tube problems conservatively
managed, Peristomal leaks, Peristomal infection, Mild skin
necrosis, Wound granulation, Minor wound bleeding, Wound
hematoma, Post-procedure ileus, Symptomatic pneumoperito-
neum, Subcutaneous emphysema, Regurgitation, Unsuccessful
procedure.
Information sources
The electronic databases searched were MEDLINE (via
PubMed), Embase, Scopus, LILACS, the Cochrane Library
(via BVS), and CINAHL (via EBSCO), from inception until
February 2015.
Search
The descriptors used for the study were as follows:
((Gastrostomies OR Gastrostomie OR Gastrostomy OR
Percutaneous endoscopic gastrostomy)) AND random*.
Study selection
The process of including or excluding studies according
to PRISMA is presented as a flow chart. The eligibility
assessment and selection of records shown were per-
formed independently in a standardized manner by two
reviewers. Disagreements between the reviewers were
resolved by consensus and the search was conducted in all
languages, with no limit regarding time.
Studies comparing patients undergoing endoscopic gastro-
stomy and SG were included regardless of cause and enrolled
patients aged over 18 years and with a minimum period of one
month of follow-up. Abstracts, letters, editorials, expert opinions,
case reports and reviews were excluded. Studies that did not
consider the desired outcomes or that compared other techni-
ques were also not included.
Data collection process and items
Data were extracted independently by two reviewers (JGPB,
BWM) using forms (checklists) that are standard for cohort
studies (8) and randomized clinical trials (7). The data were
drawn from all studies comparing endoscopic gastrostomy and
SG using the following as main variables: endoscopic gastro-
stomy, gastrostomy, follow-up, early and late complications and
minor and major complications. Complications not related to the
procedure, mortality not related to the procedure, were excluded.
Risk of bias
Publication bias was assessed by two independent
reviewers and retrospective and randomized studies were
evaluated separately. For retrospective studies, the New-
castle scale (18) was used based on the Jadad score for cohort
studies and randomized studies (11). The strength of evi-
dence was evaluated using the Oxford Centre’s recommen-
dations for evidence-based medicine (19). The results of the
evaluation were shown to be valid and reliable. Potential
confounding factors were identified, as many authors do not
take these important aspects into account in their analyses,
which can lead to bias. The primary outcome measures used
had also to be clearly indicated in the study. If they were not
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indicated or if the study based its findings on key secondary
endpoints, the study was rejected.
Planned methods of analysis
The analysis was performed using Review Manager
(RevMan) 5.3 (21) from the Cochrane Informatics & Knowledge
Management Department website. Risk differences for dichot-
omous variables were computed using a fixed-effects model and
the respective forest and funnel plots were obtained. Data on risk
differences and the 95% confidence intervals (CIs) for each out-
come were calculated using the Mantel-Haenszel test. Incon-
sistency (heterogeneity) was qualified and reported using the
Chi-squared (Chi2) and Higgins methods and was termed I2.
Data on the absolute risk reduction (ARR) or increase (ARI)
and the number needed to treat (NNT) or harm (NNH)
were obtained for validity and applicability using Critically
Appraised Topics (CAT) software (19).
’ RESULTS
Initially, 2,042 studies were retrieved. A total of 2,024
studies were excluded for various reasons after reading: 720
presented no direct comparison of the techniques under study,
104 were narrative reviews and another 1,200 had no direct
relation to the review. For evaluation and eligibility, the full
text of the remaining eighteen articles was read and eleven
studies were further excluded for various reasons: two studies
compared endoscopic gastrostomy with gastrojejunostomy,
six were comparative reviews of radiological and endoscopic
techniques and three were case series. Selected a total of seven
studies of the remaining studies, two were prospective rando-
mized studies and five were retrospective cohort studies. The
retrospective and randomized studies were evaluated inde-
pendently. Few randomized studies compared one technique
with the other. All strategies and the selection procedure are
represented in the diagram below (Figure 1).
Study characteristics
Seven studies were included for review, including two rando-
mized controlled trials and five retrospective cohort studies. The
total population was 406 individuals, with 232 having under-
gone endoscopic gastrostomy and 172 having undergone SG.
The main indications were neurological; traumatic; tumors of the
head and neck; and other situations, such as stenosis or eso-
phageal atresia (Table 1). All studies used the Gauderer-Ponsky
or ‘‘pull’’ endoscopic gastrostomy technique described in 1980
(17,24, 27). Certain studies did not mention whether the patients
received antibiotic prophylaxis. The main outcomes studied
were procedure-related complications, divided into major, minor
and mortality complications directly related to the procedure.
Risk of bias within studies
For the prospective randomized studies, the Jadad score
(11), ranging from 0 to 5, was used and only the studies with
a Jadad score X3 were selected. For observational studies,
the Newcastle-Ottawa rating scale (12) was used and only
studies with a score X6, of a maximum total of 9 points,
were selected. Publication bias is related to what is likely to
be published among what is available to be published
(Tables 4 and 5, Supplementary file).
Results of individual studies
Of the 406 patients in total, 232 had undergone PEG and
174 had undergone SG. Among these patients, 27 major
complications were observed, 16 of which were related to the
endoscopic procedure and 11 of which were related to the
surgical procedure. Minor complications occurred in 57 patients
with SG and in 56 with PEG. Moreover, mortality related to
the procedures was higher in the group with SG (five cases)
compared with the group with PEG (one case).
All complications in retrospective studies
In the retrospective studies, with a sample of 205 indi-
viduals, complications occurred in 125 for PEG and in 77 for
SG (23,4,6,16,29). There was no significant difference favor-
ing either group.
Major complications in retrospective studies
Of a total of 18 complications, 12 were for PEG and 6 were
for SG. There was no significant difference between the four
studies. Only one study (29) showed a significant difference
(95% CI (0.333 to 0.547), ARR=10.7%, NNT=9, i.e., it would be
necessary to treat nine patients for one to have a higher number
of complications) (Table 2). Analysis of the retrospective studies
(23,4,6,16,29) showed that the most frequent major complica-
tions were peritonitis requiring surgical intervention, aspiration
and sepsis, with certain cases resulting in death.
Minor complications in retrospective studies
Of 59 minor complications reported in the retrospec-
tive studies, 31 were for PEG and 28 were for SG; this difference
was not significant (Table 2). The most frequent complications
were small tube leaks, stoma leakage, displacement of the tube
and superficial cellulitis. There was no death related to minor
complications in most studies (Table 2) (23,4,6,16,29).
Mortality related to the procedure in
retrospective studies
Three deaths related to the procedure occurred, all of
which were following SG. The leading causes of death were
peritonitis and aspiration pneumonia. The risk difference
analysis did not show a statistically significant trend
favoring any group. Mortality occurred in only three retro-
spective studies (Table 2) (23,6,16).
All complications in randomized studies
Among the 201 patients in total, there were 104 complica-
tions for PEG and 97 for SG. In all, 29 complications were
related to PEG and 42 were related to SG. There was no
significant difference between the groups (Table 3).
Major complications in randomized studies
Four complications occurred in the PEG group and
5 occurred in the SG group. There was no significant diff-
erence between PEG and SG. The most common major
complications were pneumonia and peritonitis (Table 3).
Minor complications in randomized studies
Of 52 complications, 25 were related to PEG and 27 were
related to SG. The study by Ljungdahl et al. (14) showed that
PEG was associated with significantly fewer minor compli-
cations compared with SG (95% CI (0.124 to 0.562), ARR =
0.343, NNT=3, i.e., it would be necessary to treat three
patients for minor complications). The most common
complications were leaks around the tube, wound infection,
dislodged tubes, and stoma leakage (Table 3).
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Procedure-related mortality in randomized studies
Three deaths were related to the procedures, with one in the
PEG group and two related to SG in the study by Ljungdahl et
al. (14). In contrast, in the study by Stiegmann et al. (26), there
were no deaths related to the procedure. The main cause of
death was aspiration pneumonia. However, there was no
significant difference between PEG and SG (Table 3).
Summary of results (meta-analyses) Risk of bias
across studies and additional analyses
Risk of bias across studies and additional analyses. The
data on effect estimates and CIs for each study are illustrated
graphically below. The numerical group-specific summary
information, effect sizes, CIs and percentage weights are also
Records identified through database 
searching Medline 
(n =  410 ) 
Additional records identified through other 
sources 
EMBASE = 220,  CINAHL = 705,
LILACS = 40, 
Cochrane = 386, Scopus = 281
Records screened
(n = 2042)
Records excluded, with reasons
(n = 2024  ) 
-did not compare the techniques
directly (720)
-Narrative review (104)
Other study not related to review
(1200)
Full-text articles assessed 
for eligibility  
(n = 18)
Full-text articles excluded, with 
reasons (n = 11   ) 
-Articles that compared 
endoscopic gastrostomy to 
gastrojejunostomy (2) -Systematic 
review that compares two RIG and 
PEG (6) - Case series (3) 
Studies included in 
qualitative synthesis 
(n = 7)







Adapted from: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). 


























Figure 1 - Search strategy and selection of studies.
Table 1 - Characteristics of retrospective and randomized studies.
Authors Country Population Comparison Sample (n=523) Method Mean age (years) Follow-up
Rustom et al. (23)
2006 retrospective
England Head and neck tumors PEG 40 Pull* 63 18 M
SG 10 OSG* 65
Cosentini et al. (4)
1998 retrospective
Austria Oropharyngeal cancer, head and neck
cancer, neurological disorder
PEG 35 Pull 58 17 M
SG 4 OSG 28
Wollman et al. (30)
1995 retrospective
USA Neurological impairment, head and
neck cancer, gastrointestinal
decompression
PEG 69 Pull 61 1 M
SG 62 OSG 54
Muller et al. (16)
1999 retrospective
Sweden Neurological disorder, malignant
cancer, other
PEG 24 Pull 55 1 M
SG 14 OSG 39
Edelman et al. (6)
1994 retrospective
USA Inability to eat, malnutrition, recurrent
aspiration, head and neck or
esophageal tumor, esophageal
obstruction from radiation
PEG 17 Pull 81 1 M
SG 14 SLG* 61
Ljungdahl et al. (14)
2006 randomized
Sweden Stroke, neurological disease,
oropharyngeal cancer, cerebral trauma
PEG 35 Pull 69 45 M
SG 35 OSG 65
Stiegmann et al. (26)
1990 randomized
USA Oropharyngeal cancer, head and neck
cancer, esophageal stricture
PEG 12 Pull 48 4 M
SG 35 OSG 71
OSG: open surgical gastrostomy; SG: surgical gastrostomy; PEG: percutaneous endoscopic gastrostomy; Pull: method of percutaneous gastrostomy;
SLG: surgical laparoscopic gastrostomy.
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presented in the following tables. Sensitivity analysis was
carried out using the heterogeneity test and is represented in
the form of forest and funnel plots.
There was no statistically significant difference between PEG
and SG (risk difference = -0.04, 95% CI (-0.18 to 0.10), Figure 2a).
For major and minor complications in particular, there was no
difference between PEG and SG (risk difference = -0.00, 95%
CI (-0.11 to 0.10)), Figure 2b and risk difference = -0.04,
95% CI (-0.17 to 0.09), Figure 2c, respectively). Additionally,
for mortality related to the procedures (Figure 8), there was
no difference between PEG and SG (risk difference = -0.06,
95% CI (-0.15 to 0.03), Figure 2d). Sensitivity analysis for
retrospective studies (Figures 4-7).
In the randomized studies related to endoscopic gastrostomy,
the procedure was associated with significantly fewer complica-
tions (risk difference = -0.15, 95% CI (-0.27 to -0.03)), although
Table 2 - Statistical summary of complications and mortality for retrospective studies.
EVIDENCE SUMMARY
Authors PEG INTERV/N SG INTERV/N ARR/ARI 95% CI NNT/NNH
All complications
Rustom et al. 2006 12/40 8/10 0.100(R) -0.256 to 0.398 NS
Cosentini et al. 1998 16/24 5/14 0.071(R) -0.245 to 0.445 NS
Wollman et al. 1995 9/35 1/41 -0.007(I) -0.455 to 0.441 NS
Moller et al. 1999 2/12 1/35 -0.147(I) -0.114 to 0.408 NS
Edelman et al. 1994 4/17 1/14 0.227(R) -0.78 to 0.46 NS
128 77
Major complications
Rustom et al. 2006 0/40 1/10 0.100(R) -0.086 to 0.134 NS
Cosentini et al. 1998 4/24 2/14 -0.024(I) -0.260 to 0.212 NS
Wollman et al. 1995 5/35 1/4 0.107(R) 0.333 to 0.547 9
Moller et al. 1999 1/12 1/35 -0.054(I) -0.220 to 0.112 NS
Edelman et al. 1994 2/17 1/14 -0.047(I) -0.251 to 0.157 NS
128 77
Minor complications
Rustom et al. 2006 16/40 4/10 0.000(R) -0.339 to 0.339 NS
Cosentini et al. 1998 8/24 6/14 0.096(R) -0.225 to 0.417 NS
Wollman et al. 1995 4/35 0/4 0.114(R) -0.219 to 0.009 NS
Moller et al. 1999 1/12 10/35 0.203(R) -0.113 to 0.410 NS
Edelman et al. 1994 2/17 0/14 0.164(R) -0.406 to 0.078 NS
128 77
Procedure-related mortality
Rustom et al. 2006 0/40 1/10 0.100(R) -0.086 to 0.286 NS
Cosentini et al. 1998 0/24 0/14 0(R) 0 NS
Wollman et al. 1995 0/35 0/4 0(R) 0 NS
Moller et al. 1999 0/12 1/35 0.029(R) -0.027 to 0.085 NS
Edelman et al. 1994 0/17 1/14 0.071(R) -0.064 to 0.206 NS
128 77
PEG: percutaneous endoscopic gastrostomy; SG: surgical gastrostomy; ARR/ARI: absolute risk reduction or increase – (R): reduction, (I): increase;
95% CI: 95% confidence interval; NNT/NNH: number needed to treat or harm, (-): negative, NS: not statistically significant; Interv: intervention.
Table 3 - Statistical summary of complications and mortality for randomized studies.
EVIDENCE SUMMARY
Authors PEG INTERV/N SG INTERV/N ARR/ARI 95% CI NNT/NNH
All complications
Ljungdahl et al. 2006 13/35 27/35 0.400(R) -0.188 to 0.612 NS
Stiegmann et al. 1990 16/69 15/62 -0.010(I) -0.136 to 0.156 NS
104 97
Major complications
Ljungdahl et al. 2006 0/35 2/35 -0.057(I) -0.020 to 0.134 NS
Stiegmann et al. 1990 4/69 3/62 -0.054(I) -0.087 to 0.067 NS
104 97
Minor complications
Ljungdahl et al. 2006 13/35 25/35 0.343(R) 0.124 to 0.562 3
Stiegmann et al. 1990 12/69 12/62 0.020(R) -0.133 to 0.153 NS
104 97
Procedure-related mortality
Ljungdahl et al. 2006 1/35 2/35 0. 028(R) -0.067 to 0.123 NS
Stiegmann et al. 1990 0/69 0/62 0(R) 0 NS
104 97
PEG: percutaneous endoscopic gastrostomy; SG: surgical gastrostomy; ARR/ARI: absolute risk reduction or increase – (R): reduction, (I): increase; 95% CI:
95% confidence interval; NNT/NNH: number needed to treat or harm, (-): negative, NS: not statistically significant ; Interv: intervention.
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high heterogeneity (I2=89%) was present (Figure 3a1-a2). The
study by Ljungdahl (3) was outside of the funnel, which could
indicate important bias in the interpretation (Figure 8a, Supple-
mentary file) that PEG is associated with fewer complications.
Furthermore, its weight in the analysis was 34% lower
compared with the value in the study by Stiegmann (14) or at
65.1%, which led to a new analysis of sensitivity and exclusion
of the study by Ljungdahl (3) (Figure 8b, Supplementary file).
No significant difference was found (risk difference = -0.01, 95%
CI (-0.22 to 0.20)) between PEG and SG (Figure 3a1-a2).
Regarding major complications in the randomized studies,
the forest plot demonstrated no significant difference between
PEG and SG (risk difference = -0.01, 95% CI (-0.07 to 0.05),
Figure 3b). In sensitivity analysis funnel plot of major complica-
tions in randomized studies. All studies are inside the funnel
plot (Figure 9). Regarding minor complications in the rando-
mized studies, the forest plot showed that PEG was associated
with significantly fewer complications compared with SG (risk
difference = -0.13, 95% CI (-0.25 to -0.02)). There was great
heterogeneity between studies, which may have been due to
the varying characteristics of the studies, times of publication
and distributions of the populations as well as other population
differences (Figure 3c). In the analysis of sensitivity, two studies
were found to lie inside the funnel plot, demonstrating true
heterogeneity (Figure 10, Supplementary file). Regarding mor-
tality related to the procedures in the randomized studies, there
was no significant difference between PEG and SG (risk
difference = -0.01, 95% CI (-0.05 to 0.03), Figure 3d).
’ DISCUSSION
The aim of the present systematic review and meta-analysis
was to compare the complications and mortality directly
related to PEG and SG. Seven studies were included, namely,
two prospective randomized studies and five retrospective
studies and these were evaluated differently, given that there
are few published randomized studies comparing the two
techniques. The review demonstrates, via separate analyses of
the randomized trials, that endoscopic gastrostomy has a low
Figure 2 - Summary of meta-analysis of retrospective studies. (A) meta-analysis--all complications in retrospective studies. (B) meta-
analysis of major complications in retrospective studies. (C) meta-analysis of minor complications in retrospective studies. (D) meta-
analysis of mortality related to procedures in retrospective studies.
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Figure 3 - Summary of meta-analysis of randomized studies. (A1-A2) meta-analysis of all complications for randomized trials. (B) meta-
analysis of major complications in randomized studies. (C) meta-analysis of minor complications in randomized studies. (D) meta-
analysis of mortality related to procedures in randomized studies.
Figure 4 - Funnel plot of all complications in retrospective
studies. All studies are inside the funnel plot.
Figure 5 - Funnel plot of major complications in retrospective
studies. All studies are inside the funnel plot.
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rate of minor complications compared with SG. In contrast,
the retrospective studies exhibited no significant differences.
Endoscopic gastrostomy is used as the method of choice in
nearly all centers worldwide, replacing SG (24,25,30). Many
studies indicate that SG is associated with more complications
and higher mortality, mainly because it is a more invasive
procedure with a longer recovery period. In addition, this
method is more expensive and involves operating room
reservations and an anesthesia team in 100% of cases and in
certain cases, patients need intensive care. Although more
practical, SG is also associated with complications and
mortality. In particular, several studies have reported many
complications and considerable cases of mortality linked
to this procedure and there have additionally been many
unreported cases of complications and mortality directly
associated with the procedure (12,13). Many of these com-
plications and cases of mortality involve seriously ill patients,
the bedridden, or the elderly, with multiple comorbidities
during hospitalization.
Despite high heterogeneity in the randomized studies
(14,26), in the sensitivity analysis, it was found that there was
true heterogeneity and inconsistency (outliers outside of the
funnel). There were no significant differences between the
two techniques regarding major complications or mortality
related to the procedure in either the retrospective or
randomized studies. Analysis of overall complications in
the randomized trials revealed that SG had a higher rate of
complications, but when sensitivity was analyzed and
discrepancies (outliers) were removed, there was no differ-
ence between the two techniques.
Another problem is the lack of adequate standardization in
the literature regarding the definitions of major and minor
complications, which has also been a key factor in increasing
bias. Both SG and endoscopic gastrostomy are associated
with many complications, large and small. Specifically, there
are many reports of complications that led to the death of
patients as a result of associated diseases. For example, Grant
et al. (9) assessed complications of PEG in patients with head
and neck tumors; a total of 253 gastrostomy cases were
observed, with 1% of deaths, 3.3% of minor complications
and 28.9% of major complications related to PEG. Addition-
ally, many studies do not report whether they used
antibiotics for prophylaxis, which reduces complications
and mortality from infections. In a study by Lipp et al. (1),
1,100 patients in ten randomized clinical trials were
evaluated and the use of antibiotic prophylaxis was found
to reduce complications related to infections (1). In the
present review and meta-analysis, the main major complica-
tions reported were pneumonia aspiration, sepsis, and
peritonitis, and the main minor complications were wound
Figure 6 - Funnel plot of major complications in retrospective
studies. All studies are inside the funnel plot.
Figure 7 - Funnel plot of mortality related to procedures in
retrospective studies. All studies are inside the funnel plot.
Figure 8 - Funnel plot of all complications in randomized studies. The study by Ljungdahl (3) was outside of the funnel, which could
indicate important bias in the interpretation (Figure 8a, Supplementary file) that PEG is associated with fewer complications.
Furthermore, its weight in the analysis was 34% lower compared with the value in the study by Stiegmann (14), or 65.1%, which led to
a new analysis of sensitivity and exclusion of the study by Ljungdahl (3) (Figure 8b, Supplementary file).
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infection, probe displacement, and leakage at the site of the
puncture.
Limitations
 Few randomized studies are available in the literature
 There is a lack of recent studies comparing the two
techniques using the means available today
 There is a lack of uniformity in surgical techniques in
studies
 Certain studies do not mention whether they used antibiotic
prophylaxis or not
 Many retrospective studies have a small population
 There is a lack of standardization regarding major and
minor complications
This review indicates that PEG and SG are equivalent
methods based on the evidence and that, furthermore, PEG is
associated with fewer comorbidities.
Separate analysis of retrospective and randomized studies
revealed no differences between the methods in relation to
mortality and major complications, with low levels of minor
complications for endoscopic procedures in randomized
studies and no difference observed when compared with
retrospective studies.
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